Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia

NCT04527354 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Infection
Fibrosis Lung

Interventions

DRUG: Treamid
DRUG: Placebo

Sponsor

PHARMENTERPRISES LLC